Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

91.19
-0.5100-0.56%
Post-market: 91.800.6100+0.67%19:59 EDT
Volume:3.38M
Turnover:308.78M
Market Cap:50.98B
PE:26.59
High:92.66
Open:92.43
Low:90.29
Close:91.70
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:1.34
T/O Rate:0.68%
Dividend:1.12
Dividend Rate:1.23%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.25
PE(LYR):29.51

Loading ...

Belpointe OZ Says Sarasota Aster & Links Apartments Reach About 90% Leased

Reuters
·
Sep 01

Enovis CEO, CFO to Speak at Wells Fargo HealthCare Conference Fireside Chat

Reuters
·
Sep 01

Postal Realty Trust Gets Inaugural BBB Rating from Fitch

Reuters
·
Sep 01

Rakovina Therapeutics Closes Upsized Private Placement Raising $1.99 Million

Reuters
·
Sep 01

SI-BONE to Present at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 01

Kyntra Bio Prepays USD 42.6 Million Under Amended Royalty Financing Deal

Reuters
·
Sep 01

Teva, Trump Administration Pursue Medicaid Drug Pricing Agreement Under Generous Framework

Reuters
·
Sep 01

SL Green Updates Financial Calendar with Q3 Earnings Release and Conference Call Scheduled

Reuters
·
Sep 01

NanoXplore to Host Webcast on Fourth-Quarter Results

Reuters
·
Sep 01

Clover Health Interim CFO Clay Thornton Presents at Jefferies Healthcare Services and Technology Conference

Reuters
·
Sep 01

BranchOut Food Raises USD 3.2 Million as Underwriters Fully Exercise Over-Allotment in Follow-on Offering

Reuters
·
Sep 01

Avista Seeks WUTC Review of Washington Natural Gas Rate Cut Proposal

Reuters
·
Sep 01

Middlesex Water Unit Tidewater Utilities Issues $0.5 Million PFAS Bill Credit to Customers

Reuters
·
Sep 01

Oxbridge Re Executive Team Attends Rendez-Vous De Septembre Reinsurance Conference

Reuters
·
Sep 01

Inventiva Names Chris Benecchi Chief Operating Officer

Reuters
·
Sep 01

Health Catalyst Management to Attend Wells Fargo Healthcare Conference

Reuters
·
Sep 01

SciSparc Subsidiary NeuroThera Labs Enrolls 26 Children in SCI-210 Autism Trial

Reuters
·
Sep 01

PMV Pharma Launches Underwritten Public Offering of Common Stock, Warrants

Reuters
·
Sep 01

PMV Pharma Says Rezatapopt Posts 46% Response Rate in Phase 2 Platinum-Resistant Ovarian Cancer Trial

Reuters
·
Sep 01

NorthStrive Acquisition Units Begin Separate Trading of Shares, Rights and Warrants Sept. 2

Reuters
·
Sep 01